z-logo
open-access-imgOpen Access
CHEMISTRY AND ANTITUMOUR ACTIVITY OF 5-BROMOURACILE’S DERIVATIVES
Author(s) -
Elena Welchinskaya
Publication year - 2013
Publication title -
cbu international conference proceedings ...
Language(s) - English
Resource type - Journals
eISSN - 1805-997X
pISSN - 1805-9961
DOI - 10.12955/cbup.v1.45
Subject(s) - chemistry , derivative (finance) , combinatorial chemistry , stereochemistry , medicinal chemistry , economics , financial economics
Problemofthetreatmentof man’scancerandsearchoftheeffective, withalittletoxicityantitumourmedicalproducts,isonefromtheimportant taskatthecontemporaneous medicine and pharmaceutical chemistry. Chemicalmodificationofmolecularof5-bromouracilewithnextinvestigationoftoxicity and antitumour activityofits newderivativeswhichsynthesized is described. Physical-chemical, statistical pharmacological, toxicological methods were used. A strongly antitumour effect has been discovered for bis-derivative of 5-bromouracile for the first time. A new convenient methods for the preparation of new mono- and bis-derivatives of 5-bromouracile with 1,1,1-trifluoro-2-bromo-2-chloroethane (ftorotan) and 1,1-diethylcarboxy-2-chloro-2-trifluoromethylethylene is described. The reactions are catalyzed by the DB-18-crown-6-complex. It was tested on the heterotransplantates of man’s glioma cancer of brain (by Bogden’s under capsule-method). It is permits to consider the new bis-derivative of 5-bromouracile as physiological active with a perspective investigation as potential antitumour drugs for treatment of man in future.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here